A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks.Digital Companion Diagnostics (CD) refer to a type of in vitro diagnostic tests or assays that are intended to help physicians in making effective treatment decisions based on the patient’s response to a specific drug targeted toward a specific biomarker, expressed in a particular disease or indication. The patient’s response to an ongoing therapy is mapped with the help of companion diagnostics in terms of changes in gene amplification, nullifying the effect of mutations, changes in protein overexpression and receptor-substrate interaction, and so on.

The global market for Digital Companion Diagnostics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Digital Companion Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Digital Companion Diagnostics by region & country, by Type, and by Application.

The Digital Companion Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Companion Diagnostics.

Market Segmentation

Scope of Digital Companion Diagnostics - Market Report

Report Metric	Details
Report Name	Digital Companion Diagnostics - Market
CAGR	5%
Segment by Type:	Polymerase Chain Reaction (PCR) Immunohistochemistry (IHC) In Situ Hybridization (ISH) Next Generation Sequencing (NGS)
Segment by Application	Breast Cancer Melanoma Lung Cancer Colorectal Cancer Infectious Disease Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Myriad Genetic Laboratories, Inc., Qiagen Manchester, Ltd., Roche, Dako North America, Abbott, ICON plc, Illumina, Inc, Thermo Fisher
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Digital Companion Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Digital Companion Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Digital Companion Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Digital Companion Diagnostics - Market report?

Ans: The main players in the Digital Companion Diagnostics - Market are Myriad Genetic Laboratories, Inc., Qiagen Manchester, Ltd., Roche, Dako North America, Abbott, ICON plc, Illumina, Inc, Thermo Fisher

What are the Application segmentation covered in the Digital Companion Diagnostics - Market report?

Ans: The Applications covered in the Digital Companion Diagnostics - Market report are Breast Cancer, Melanoma, Lung Cancer, Colorectal Cancer, Infectious Disease, Others

What are the Type segmentation covered in the Digital Companion Diagnostics - Market report?

Ans: The Types covered in the Digital Companion Diagnostics - Market report are Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Next Generation Sequencing (NGS)

1 Market Overview

1.1 Digital Companion Diagnostics Product Introduction

1.2 Global Digital Companion Diagnostics Market Size Forecast

1.3 Digital Companion Diagnostics Market Trends & Drivers

1.3.1 Digital Companion Diagnostics Industry Trends

1.3.2 Digital Companion Diagnostics Market Drivers & Opportunity

1.3.3 Digital Companion Diagnostics Market Challenges

1.3.4 Digital Companion Diagnostics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Digital Companion Diagnostics Players Revenue Ranking (2023)

2.2 Global Digital Companion Diagnostics Revenue by Company (2019-2024)

2.3 Key Companies Digital Companion Diagnostics Manufacturing Base Distribution and Headquarters

2.4 Key Companies Digital Companion Diagnostics Product Offered

2.5 Key Companies Time to Begin Mass Production of Digital Companion Diagnostics

2.6 Digital Companion Diagnostics Market Competitive Analysis

2.6.1 Digital Companion Diagnostics Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Digital Companion Diagnostics Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Companion Diagnostics as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Polymerase Chain Reaction (PCR)

3.1.2 Immunohistochemistry (IHC)

3.1.3 In Situ Hybridization (ISH)

3.1.4 Next Generation Sequencing (NGS)

3.2 Global Digital Companion Diagnostics Sales Value by Type

3.2.1 Global Digital Companion Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Digital Companion Diagnostics Sales Value, by Type (2019-2030)

3.2.3 Global Digital Companion Diagnostics Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Breast Cancer

4.1.2 Melanoma

4.1.3 Lung Cancer

4.1.4 Colorectal Cancer

4.1.5 Infectious Disease

4.1.6 Others

4.2 Global Digital Companion Diagnostics Sales Value by Application

4.2.1 Global Digital Companion Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Digital Companion Diagnostics Sales Value, by Application (2019-2030)

4.2.3 Global Digital Companion Diagnostics Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Digital Companion Diagnostics Sales Value by Region

5.1.1 Global Digital Companion Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Digital Companion Diagnostics Sales Value by Region (2019-2024)

5.1.3 Global Digital Companion Diagnostics Sales Value by Region (2025-2030)

5.1.4 Global Digital Companion Diagnostics Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Digital Companion Diagnostics Sales Value, 2019-2030

5.2.2 North America Digital Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Digital Companion Diagnostics Sales Value, 2019-2030

5.3.2 Europe Digital Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Digital Companion Diagnostics Sales Value, 2019-2030

5.4.2 Asia Pacific Digital Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Digital Companion Diagnostics Sales Value, 2019-2030

5.5.2 South America Digital Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Digital Companion Diagnostics Sales Value, 2019-2030

5.6.2 Middle East & Africa Digital Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Digital Companion Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Digital Companion Diagnostics Sales Value

6.3 United States

6.3.1 United States Digital Companion Diagnostics Sales Value, 2019-2030

6.3.2 United States Digital Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Digital Companion Diagnostics Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Digital Companion Diagnostics Sales Value, 2019-2030

6.4.2 Europe Digital Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Digital Companion Diagnostics Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Digital Companion Diagnostics Sales Value, 2019-2030

6.5.2 China Digital Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

6.5.3 China Digital Companion Diagnostics Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Digital Companion Diagnostics Sales Value, 2019-2030

6.6.2 Japan Digital Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Digital Companion Diagnostics Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Digital Companion Diagnostics Sales Value, 2019-2030

6.7.2 South Korea Digital Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Digital Companion Diagnostics Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Digital Companion Diagnostics Sales Value, 2019-2030

6.8.2 Southeast Asia Digital Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Digital Companion Diagnostics Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Digital Companion Diagnostics Sales Value, 2019-2030

6.9.2 India Digital Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

6.9.3 India Digital Companion Diagnostics Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Myriad Genetic Laboratories, Inc.

7.1.1 Myriad Genetic Laboratories, Inc. Profile

7.1.2 Myriad Genetic Laboratories, Inc. Main Business

7.1.3 Myriad Genetic Laboratories, Inc. Digital Companion Diagnostics Products, Services and Solutions

7.1.4 Myriad Genetic Laboratories, Inc. Digital Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.1.5 Myriad Genetic Laboratories, Inc. Recent Developments

7.2 Qiagen Manchester, Ltd.

7.2.1 Qiagen Manchester, Ltd. Profile

7.2.2 Qiagen Manchester, Ltd. Main Business

7.2.3 Qiagen Manchester, Ltd. Digital Companion Diagnostics Products, Services and Solutions

7.2.4 Qiagen Manchester, Ltd. Digital Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.2.5 Qiagen Manchester, Ltd. Recent Developments

7.3 Roche

7.3.1 Roche Profile

7.3.2 Roche Main Business

7.3.3 Roche Digital Companion Diagnostics Products, Services and Solutions

7.3.4 Roche Digital Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.3.5 Dako North America Recent Developments

7.4 Dako North America

7.4.1 Dako North America Profile

7.4.2 Dako North America Main Business

7.4.3 Dako North America Digital Companion Diagnostics Products, Services and Solutions

7.4.4 Dako North America Digital Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.4.5 Dako North America Recent Developments

7.5 Abbott

7.5.1 Abbott Profile

7.5.2 Abbott Main Business

7.5.3 Abbott Digital Companion Diagnostics Products, Services and Solutions

7.5.4 Abbott Digital Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.5.5 Abbott Recent Developments

7.6 ICON plc

7.6.1 ICON plc Profile

7.6.2 ICON plc Main Business

7.6.3 ICON plc Digital Companion Diagnostics Products, Services and Solutions

7.6.4 ICON plc Digital Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.6.5 ICON plc Recent Developments

7.7 Illumina, Inc

7.7.1 Illumina, Inc Profile

7.7.2 Illumina, Inc Main Business

7.7.3 Illumina, Inc Digital Companion Diagnostics Products, Services and Solutions

7.7.4 Illumina, Inc Digital Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.7.5 Illumina, Inc Recent Developments

7.8 Thermo Fisher

7.8.1 Thermo Fisher Profile

7.8.2 Thermo Fisher Main Business

7.8.3 Thermo Fisher Digital Companion Diagnostics Products, Services and Solutions

7.8.4 Thermo Fisher Digital Companion Diagnostics Revenue (US$ Million) & (2019-2024)

7.8.5 Thermo Fisher Recent Developments

8 Industry Chain Analysis

8.1 Digital Companion Diagnostics Industrial Chain

8.2 Digital Companion Diagnostics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Digital Companion Diagnostics Sales Model

8.5.2 Sales Channel

8.5.3 Digital Companion Diagnostics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Myriad Genetic Laboratories Inc.

Qiagen Manchester, Ltd.

Dako North America

List of Tables

Table 1. Digital Companion Diagnostics Market Trends

Table 2. Digital Companion Diagnostics Market Drivers & Opportunity

Table 3. Digital Companion Diagnostics Market Challenges

Table 4. Digital Companion Diagnostics Market Restraints

Table 5. Global Digital Companion Diagnostics Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Digital Companion Diagnostics Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Digital Companion Diagnostics Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Digital Companion Diagnostics Product Type

Table 9. Key Companies Time to Begin Mass Production of Digital Companion Diagnostics

Table 10. Global Digital Companion Diagnostics Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Companion Diagnostics as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Digital Companion Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Digital Companion Diagnostics Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Digital Companion Diagnostics Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Digital Companion Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Digital Companion Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Digital Companion Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Digital Companion Diagnostics Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Digital Companion Diagnostics Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Digital Companion Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Digital Companion Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Digital Companion Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Digital Companion Diagnostics Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Digital Companion Diagnostics Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Digital Companion Diagnostics Sales Value by Region (2019-2024) & (%)

Table 27. Global Digital Companion Diagnostics Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Digital Companion Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Digital Companion Diagnostics Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Digital Companion Diagnostics Sales Value, (2025-2030) & (US$ Million)

Table 31. Myriad Genetic Laboratories, Inc. Basic Information List

Table 32. Myriad Genetic Laboratories, Inc. Description and Business Overview

Table 33. Myriad Genetic Laboratories, Inc. Digital Companion Diagnostics Products, Services and Solutions

Table 34. Revenue (US$ Million) in Digital Companion Diagnostics Business of Myriad Genetic Laboratories, Inc. (2019-2024)

Table 35. Myriad Genetic Laboratories, Inc. Recent Developments

Table 36. Qiagen Manchester, Ltd. Basic Information List

Table 37. Qiagen Manchester, Ltd. Description and Business Overview

Table 38. Qiagen Manchester, Ltd. Digital Companion Diagnostics Products, Services and Solutions

Table 39. Revenue (US$ Million) in Digital Companion Diagnostics Business of Qiagen Manchester, Ltd. (2019-2024)

Table 40. Qiagen Manchester, Ltd. Recent Developments

Table 41. Roche Basic Information List

Table 42. Roche Description and Business Overview

Table 43. Roche Digital Companion Diagnostics Products, Services and Solutions

Table 44. Revenue (US$ Million) in Digital Companion Diagnostics Business of Roche (2019-2024)

Table 45. Roche Recent Developments

Table 46. Dako North America Basic Information List

Table 47. Dako North America Description and Business Overview

Table 48. Dako North America Digital Companion Diagnostics Products, Services and Solutions

Table 49. Revenue (US$ Million) in Digital Companion Diagnostics Business of Dako North America (2019-2024)

Table 50. Dako North America Recent Developments

Table 51. Abbott Basic Information List

Table 52. Abbott Description and Business Overview

Table 53. Abbott Digital Companion Diagnostics Products, Services and Solutions

Table 54. Revenue (US$ Million) in Digital Companion Diagnostics Business of Abbott (2019-2024)

Table 55. Abbott Recent Developments

Table 56. ICON plc Basic Information List

Table 57. ICON plc Description and Business Overview

Table 58. ICON plc Digital Companion Diagnostics Products, Services and Solutions

Table 59. Revenue (US$ Million) in Digital Companion Diagnostics Business of ICON plc (2019-2024)

Table 60. ICON plc Recent Developments

Table 61. Illumina, Inc Basic Information List

Table 62. Illumina, Inc Description and Business Overview

Table 63. Illumina, Inc Digital Companion Diagnostics Products, Services and Solutions

Table 64. Revenue (US$ Million) in Digital Companion Diagnostics Business of Illumina, Inc (2019-2024)

Table 65. Illumina, Inc Recent Developments

Table 66. Thermo Fisher Basic Information List

Table 67. Thermo Fisher Description and Business Overview

Table 68. Thermo Fisher Digital Companion Diagnostics Products, Services and Solutions

Table 69. Revenue (US$ Million) in Digital Companion Diagnostics Business of Thermo Fisher (2019-2024)

Table 70. Thermo Fisher Recent Developments

Table 71. Key Raw Materials Lists

Table 72. Raw Materials Key Suppliers Lists

Table 73. Digital Companion Diagnostics Downstream Customers

Table 74. Digital Companion Diagnostics Distributors List

Table 75. Research Programs/Design for This Report

Table 76. Key Data Information from Secondary Sources

Table 77. Key Data Information from Primary Sources

Table 78. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Digital Companion Diagnostics Product Picture

Figure 2. Global Digital Companion Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Digital Companion Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 4. Digital Companion Diagnostics Report Years Considered

Figure 5. Global Digital Companion Diagnostics Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Digital Companion Diagnostics Revenue in 2023

Figure 7. Digital Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Polymerase Chain Reaction (PCR) Picture

Figure 9. Immunohistochemistry (IHC) Picture

Figure 10. In Situ Hybridization (ISH) Picture

Figure 11. Next Generation Sequencing (NGS) Picture

Figure 12. Global Digital Companion Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 13. Global Digital Companion Diagnostics Sales Value Market Share by Type, 2023 & 2030

Figure 14. Product Picture of Breast Cancer

Figure 15. Product Picture of Melanoma

Figure 16. Product Picture of Lung Cancer

Figure 17. Product Picture of Colorectal Cancer

Figure 18. Product Picture of Infectious Disease

Figure 19. Product Picture of Others

Figure 20. Global Digital Companion Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Digital Companion Diagnostics Sales Value Market Share by Application, 2023 & 2030

Figure 22. North America Digital Companion Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 23. North America Digital Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 24. Europe Digital Companion Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 25. Europe Digital Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 26. Asia Pacific Digital Companion Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 27. Asia Pacific Digital Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 28. South America Digital Companion Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 29. South America Digital Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 30. Middle East & Africa Digital Companion Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 31. Middle East & Africa Digital Companion Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 32. Key Countries/Regions Digital Companion Diagnostics Sales Value (%), (2019-2030)

Figure 33. United States Digital Companion Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 34. United States Digital Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 35. United States Digital Companion Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 36. Europe Digital Companion Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 37. Europe Digital Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 38. Europe Digital Companion Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 39. China Digital Companion Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 40. China Digital Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 41. China Digital Companion Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 42. Japan Digital Companion Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 43. Japan Digital Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 44. Japan Digital Companion Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 45. South Korea Digital Companion Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 46. South Korea Digital Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 47. South Korea Digital Companion Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 48. Southeast Asia Digital Companion Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 49. Southeast Asia Digital Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 50. Southeast Asia Digital Companion Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 51. India Digital Companion Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 52. India Digital Companion Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 53. India Digital Companion Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 54. Digital Companion Diagnostics Industrial Chain

Figure 55. Digital Companion Diagnostics Manufacturing Cost Structure

Figure 56. Channels of Distribution (Direct Sales, and Distribution)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions